DAO and inflammatory bowel disease: It is worth noting that through network pharmacological analysis, we found that XNJ also has an impact on IBD, and the main pathway involved the T cell receptor signaling pathway, NF-kappa B signaling pathway, gap junction, etc. Guo and Liu found that XNJ reduced DAO and L/M and protected intestinal mucosal function [24].